Positioning Artificial Intelligence to Help Explain Unexpected Cancer Trial Outcomes - OncLive

AI is being used to analyze why some cancer clinical trials produce unexpected results, potentially helping doctors better understand treatment failures and improve future drug development. This matters to patients and professionals in oncology because better analysis could lead to more effective cancer therapies.